Canopy Partners, LLC Novartis Ag Transaction History
Canopy Partners, LLC
- $205 Billion
- Q1 2024
A detailed history of Canopy Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Canopy Partners, LLC holds 3,098 shares of NVS stock, worth $330,804. This represents 0.15% of its overall portfolio holdings.
Number of Shares
3,098
Previous 2,795
10.84%
Holding current value
$330,804
Previous $282 Million
6.19%
% of portfolio
0.15%
Previous 0.17%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,349Shares Held
140MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.33 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.32 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$775 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$643 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$632 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $230B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...